2016 Symposium
The First Annual Canine Comparative Oncology Symposium was held on March 4, 2016 at the SAS Executive Center in Cary, North Carolina. This day long symposium was an exciting opportunity to bring together leaders in this field and highlight comparative oncology work being done at both Duke University and NC State University. The final agenda is now available.
2016 Symposium Details
Keynote Speaker:
Amy K. LeBlanc, DVM Diplomate ACVIM (Oncology)
Director, Comparative Oncology Program
NCI Center for Cancer Research
Location:
SAS Executive Briefing Center (EBC) March 4, 2016: 7:30am-5:00pm
2016 Presentations
Welcome, Overview and Introduction of Pilot Project RFA
- Michael B. Kastan, MD, PhD, Executive Director, Duke Cancer Institute
Panel One: Setting the Stage
- Rodney Page, DVM, MS, Colorado State University
- Matthew Breen, PhD, NCSU College of Veterinary Medicine
- Elaine A. Ostrander, PhD, National Human Genome Research Institute
- William Eward, DVM, MD, Duke Cancer Institute
Discussion
- Matthew Breen, PhD, NCSU College of Veterinary Medicine (moderator)
Partnership and What It Means Across Campuses: An Optimal Model, Defining Collaboration and What We Need for Success
- Mark Dewhirst, DVM, PhD, Duke Cancer Institute
- Michael S. Kent, DVM, University of California Davis
- Eric J. Bernhard, PhD, National Cancer Institute
Discussion
- Mark Dewhirst, DVM, PhD, Duke Cancer Institute (moderator)
Panel Two: Cultivating the Science
- Deborah Knapp, DVM, MS, Purdue University College of Veterinary Medicine
- Kristy Richards, MD, PhD, Cornell University College of Veterinary Medicine
Cross Species Clinical Trials – Using a Multi-Species Approach
- Mark Dewhirst, DVM, PhD, Duke Cancer Institute
- David Kirsch, MD, PhD, Duke Cancer Institute
Comparative Pharmacokinetic Studies in Human and Canine Cancer Patients
- Mark Dewhirst, DVM, PhD, Duke Cancer Institute
Discussion
- Neil Spector, MD, Duke Cancer Institute (moderator)
Keynote Address
- Marlene Hauck, DVM, PhD, NCSU College of Veterinary Medicine
Comparative Oncology at the NIH: An Integrative Approach to Cancer Research and Drug Development
- Amy K. LeBlanc, DVM Diplomate ACVIM (Oncology) Director, Comparative Oncology Program, National Cancer Institute
Closing Remarks
Poster Session and Refreshments